Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433505
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-05-23
Brief Title:
A Study to Evaluate the Drug Levels Metabolism and Excretion and Absolute Bioavailability of BMS-986365 in Healthy Male Participants
Sponsor:
Celgene
Organization:
Celgene
Study Overview
Official Title:
A Phase 1 Open-label Two-Part Study to Evaluate the Pharmacokinetics Metabolism and Excretion and Absolute Bioavailability of BMS-986365 in Healthy Male Participants
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the pharmacokinetics PK and absolute bioavailability of BMS-986365 and to investigate the PK metabolite profile routes and extent of elimination and mass balance of BMS-986365
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None